IBDEI2SM ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46888,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,46888,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,46888,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,46889,0)
 ;;=L30.8^^206^2313^9
 ;;^UTILITY(U,$J,358.3,46889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46889,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,46889,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,46889,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,46890,0)
 ;;=L40.0^^206^2313^16
 ;;^UTILITY(U,$J,358.3,46890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46890,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,46890,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,46890,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,46891,0)
 ;;=L40.9^^206^2313^17
 ;;^UTILITY(U,$J,358.3,46891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46891,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,46891,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,46891,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,46892,0)
 ;;=L40.3^^206^2313^19
 ;;^UTILITY(U,$J,358.3,46892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46892,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,46892,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,46892,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,46893,0)
 ;;=R21.^^206^2313^20
 ;;^UTILITY(U,$J,358.3,46893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46893,1,3,0)
 ;;=3^Rash/Oth Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,46893,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,46893,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,46894,0)
 ;;=L25.9^^206^2313^6
 ;;^UTILITY(U,$J,358.3,46894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46894,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,46894,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,46894,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,46895,0)
 ;;=M34.89^^206^2314^22
 ;;^UTILITY(U,$J,358.3,46895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46895,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,46895,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,46895,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,46896,0)
 ;;=M34.0^^206^2314^20
 ;;^UTILITY(U,$J,358.3,46896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46896,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,46896,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,46896,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,46897,0)
 ;;=F03.90^^206^2314^14
 ;;^UTILITY(U,$J,358.3,46897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46897,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,46897,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,46897,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,46898,0)
 ;;=F06.8^^206^2314^17
 ;;^UTILITY(U,$J,358.3,46898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46898,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,46898,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,46898,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,46899,0)
 ;;=F06.1^^206^2314^1
 ;;^UTILITY(U,$J,358.3,46899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46899,1,3,0)
 ;;=3^Catatonic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,46899,1,4,0)
 ;;=4^F06.1
 ;;^UTILITY(U,$J,358.3,46899,2)
 ;;=^5003054
 ;;^UTILITY(U,$J,358.3,46900,0)
 ;;=G35.^^206^2314^18
 ;;^UTILITY(U,$J,358.3,46900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46900,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,46900,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,46900,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,46901,0)
 ;;=G60.9^^206^2314^15
 ;;^UTILITY(U,$J,358.3,46901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46901,1,3,0)
 ;;=3^Hereditary/Idiopathic Neuropathy,Unspec
